Mahdi Paryan
Overview
Explore the profile of Mahdi Paryan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
441
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shojaei S, Moradi-Chaleshtori M, Paryan M, Koochaki A, Sharifi K, Mohammadi-Yeganeh S
Eur J Med Res
. 2023 Nov;
28(1):516.
PMID: 37968694
Background: The epithelial-mesenchymal transition (EMT) and angiogenesis are morphogenetic processes implicated in tumor invasion and metastasis. It is found that the aberrant expression of microRNAs (miRNAs) contributes to these processes....
2.
Anajafi S, Paryan M, Khoshnazar A, Soleimani M, Mohammadi-Yeganeh S
Endocr Metab Immune Disord Drug Targets
. 2023 Aug;
24(3):333-347.
PMID: 37612874
Cancer-associated fibroblasts (CAFs) as a major component of cancer stroma contribute to diverse procedures of most solid tumors and might be a targeted cancer therapy approach. Their specified features, related...
3.
Goodarzi M, Jalalirad R, Doroud D, Hozouri H, Aghasadeghi M, Paryan M
Sci Rep
. 2023 Jul;
13(1):10745.
PMID: 37400485
The difficulties in purification of VLP-based recombinant hepatitis B surface antigen (rHBsAg) are mainly emerged from inefficient semi-purification step plus proteins physicochemical properties and these issues make the downstream processing...
4.
Hosseini V, Paryan M, Koochaki A, Cesaire H, Mohammadi-Yeganeh S
J Bone Miner Metab
. 2023 May;
41(4):481-491.
PMID: 37247112
Introduction: Mesenchymal stem cells (MSCs) are drawing considerable attention in the field of regenerative medicine due to their differentiation capabilities. The miRNAs are among the most important epigenetic regulators of...
5.
Ghalavand M, Esmaeili Gouvarchin Ghaleh H, Khafaei M, Paryan M, Jalali Kondori B, Nodoushan M, et al.
Endocr Metab Immune Disord Drug Targets
. 2023 Jan;
23(8):1096-1103.
PMID: 36705241
Background: Allergic asthma is a chronic inflammatory illness of the respiratory system characterized by an increase in the number of inflammatory cells in the airways and trouble breathing. Mesenchymal stem...
6.
Ghorbani M, Shokri R, Kia V, Yari F, Sharifi Z, Paryan M
Indian J Med Microbiol
. 2022 Aug;
40(4):560-566.
PMID: 35914958
Purpose: HBV DNA quantification is used for individuals with uninterpretable serological tests, occult HBV infections, decreasing the window period of the disease, and treatment follow-up. Although there are commercial qPCR...
7.
Kia V, Tafti A, Paryan M, Mohammadi-Yeganeh S
Ir J Med Sci
. 2022 Jun;
192(2):723-729.
PMID: 35668337
Purpose: In January 2020, the COVID-19 pandemic started and has severely affected all countries around the world. The clinical symptoms alone are not sufficient for a proper diagnosis. Thus, molecular...
8.
Moradi-Chaleshtori M, Koochaki A, Shojaei S, Paryan M, Safarzadeh M, Hashemi S, et al.
Immunol Lett
. 2022 Jun;
248:31-36.
PMID: 35667453
M2 macrophages, the major component of tumor microenvironment, are recognized as important player in tumor progression. M2 macrophages mediate this effect by promoting tumor angiogenesis, tumor metastasis, and suppression of...
9.
Azimi T, Paryan M, Mondanizadeh M, Sarmadian H, Zamani A
Asian Pac J Cancer Prev
. 2021 Apr;
22(4):1271-1277.
PMID: 33906322
Background: one of the female-specific diseases with a high incidence and mortality is cervical cancer. The main cause of cervical cancer is infection with Human papilloma virus (HPV). Low-grade squamous...
10.
Pishkari S, Hadavi R, Koochaki A, Razaviyan J, Paryan M, Hashemi M, et al.
Horm Mol Biol Clin Investig
. 2021 Mar;
42(3):265-271.
PMID: 33769725
Objectives: The aim of the present study was to investigate the expression of and genes and their targeting microRNAs (miRNAs) including miR-34a and miR-144 in Medullary Thyroid Carcinoma (MTC) cell...